Cydsa, S.A.B. de C.V.

BMV:CYDSASA A Stock Report

Market Cap: Mex$9.0b

Cydsa. de Valuation

Is CYDSASA A undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CYDSASA A when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CYDSASA A (MX$16.84) is trading below our estimate of fair value (MX$84.7)

Significantly Below Fair Value: CYDSASA A is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CYDSASA A?

Key metric: As CYDSASA A is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CYDSASA A. This is calculated by dividing CYDSASA A's market cap by their current earnings.
What is CYDSASA A's PE Ratio?
PE Ratio8x
EarningsMex$1.12b
Market CapMex$8.97b

Price to Earnings Ratio vs Peers

How does CYDSASA A's PE Ratio compare to its peers?

The above table shows the PE ratio for CYDSASA A vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average11.6x
ORBIA * Orbia Advance Corporation. de
11.9x18.4%Mex$33.3b
500201 India Glycols
17.7xn/a₹34.4b
A012630 HDC HOLDINGSLtd
4.2xn/a₩545.8b
605166 Hangzhou Juheshun New MaterialLTD
12.6x26.2%CN¥3.5b
CYDSASA A Cydsa. de
8x20.9%Mex$9.0b

Price-To-Earnings vs Peers: CYDSASA A is good value based on its Price-To-Earnings Ratio (8x) compared to the peer average (11.6x).


Price to Earnings Ratio vs Industry

How does CYDSASA A's PE Ratio compare vs other companies in the Global Chemicals Industry?

36 CompaniesPrice / EarningsEstimated GrowthMarket Cap
CYDSASA A 8.0xIndustry Avg. 21.9xNo. of Companies184PE01632486480+
36 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: CYDSASA A is good value based on its Price-To-Earnings Ratio (8x) compared to the Global Chemicals industry average (21.7x).


Price to Earnings Ratio vs Fair Ratio

What is CYDSASA A's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CYDSASA A PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio8x
Fair PE Ratio9.5x

Price-To-Earnings vs Fair Ratio: CYDSASA A is good value based on its Price-To-Earnings Ratio (8x) compared to the estimated Fair Price-To-Earnings Ratio (9.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CYDSASA A forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentMex$16.84
Mex$54.00
+220.7%
16.7%Mex$63.00Mex$45.00n/a2
Nov ’25Mex$15.86
Mex$54.00
+240.5%
16.7%Mex$63.00Mex$45.00n/a2
Oct ’25Mex$15.45
Mex$54.00
+249.5%
16.7%Mex$63.00Mex$45.00n/a2
Sep ’25Mex$17.30
Mex$54.00
+212.1%
16.7%Mex$63.00Mex$45.00n/a2
Aug ’25Mex$17.85
Mex$54.00
+202.5%
16.7%Mex$63.00Mex$45.00n/a2
Jul ’25Mex$18.24
Mex$53.50
+193.3%
17.8%Mex$63.00Mex$44.00n/a2
Jun ’25Mex$19.00
Mex$53.50
+181.6%
17.8%Mex$63.00Mex$44.00n/a2
May ’25Mex$19.05
Mex$53.50
+180.8%
17.8%Mex$63.00Mex$44.00n/a2
Apr ’25Mex$19.20
Mex$50.50
+163.0%
17.5%Mex$63.00Mex$43.50n/a3
Mar ’25Mex$19.20
Mex$50.50
+163.0%
17.5%Mex$63.00Mex$43.50n/a3
Feb ’25Mex$18.55
Mex$50.50
+172.2%
21.7%Mex$66.00Mex$42.00n/a3
Jan ’25Mex$19.00
Mex$50.50
+165.8%
21.7%Mex$66.00Mex$42.00n/a3
Dec ’24Mex$16.95
Mex$50.50
+197.9%
21.7%Mex$66.00Mex$42.00n/a3
Nov ’24Mex$18.74
Mex$50.50
+169.5%
21.7%Mex$66.00Mex$42.00Mex$15.863
Oct ’24n/a
Mex$50.50
0%
21.7%Mex$66.00Mex$42.00Mex$15.453
Sep ’24Mex$20.00
Mex$54.00
+170.0%
22.2%Mex$66.00Mex$42.00Mex$17.302
Aug ’24Mex$18.49
Mex$54.00
+192.0%
22.2%Mex$66.00Mex$42.00Mex$17.852
Jul ’24Mex$19.62
Mex$54.00
+175.2%
22.2%Mex$66.00Mex$42.00Mex$18.242
Jun ’24Mex$19.00
Mex$54.00
+184.2%
22.2%Mex$66.00Mex$42.00Mex$19.002
May ’24Mex$19.01
Mex$54.00
+184.1%
22.2%Mex$66.00Mex$42.00Mex$19.052
Apr ’24Mex$17.74
Mex$42.90
+141.8%
39.6%Mex$66.00Mex$25.70Mex$19.203
Mar ’24Mex$17.20
Mex$42.90
+149.4%
39.6%Mex$66.00Mex$25.70Mex$19.203
Feb ’24Mex$17.70
Mex$39.23
+121.7%
48.2%Mex$66.00Mex$25.70Mex$18.553
Jan ’24Mex$16.00
Mex$39.23
+145.2%
48.2%Mex$66.00Mex$25.70Mex$19.003
Dec ’23Mex$12.99
Mex$32.23
+148.1%
28.0%Mex$45.00Mex$25.70Mex$16.953
Nov ’23Mex$13.00
Mex$32.23
+147.9%
28.0%Mex$45.00Mex$25.70Mex$18.743

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies